Big Move For InflaRx N.V.
Tue, Jun 28, 2022 at 08:33 PM
InflaRx N.V. (IFRX:NASDAQ) rocketted at $1.52, representing a gain of 40.7%. On Tue, Jun 28, 2022, IFRX:NASDAQ hit a New 2-Week High of $1.52. From Tue, Jun 14, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days
About InflaRx N.V. (IFRX:NASDAQ)
InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.
Top 10 Gainers:
- Agile Therapeutics, Inc. (AGRX:NASDAQ), 89.76%
- Endo International plc (ENDP:NASDAQ), 85.33%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 52.17%
- Tuniu Corporation (TOUR:NASDAQ), 46.01%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 43.43%
- InflaRx N.V. (IFRX:NASDAQ), 40.74%
- EzFill Holdings Inc. (EZFL:NASDAQ), 35.59%
- Graybug Vision Inc. (GRAY:NASDAQ), 35.38%
- Motorsport Games Inc. (MSGM:NASDAQ), 29.63%